We also recommend testing for folate and ferritin (iron storage), and do a full blood count
Clarity Around Medication Types and Limitations Major issues LifeRx offers compounded semaglutide and tirzepatide injections but provides no information on the main website about what medications are actually available beyond vague language like GLP-1 Management and fine print stating its not associated with Eli Lilly or Novo Nordisk
However, the temporal association of the patient's reaction with the increase in semaglutide (Ozempic) dose, not the subsequent medications used to treat the symptoms, and resolution of rash soon after discontinuation, increases the likelihood that the GLP-1 agonist was responsible
It is making smaller portions work harder
Most contain ingredients like inositol, chromium, or plant compounds that show modest effects in isolated studies but have not demonstrated weight loss comparable to actual GLP-1 receptor agonists in human trials
FDA approval is expected in 2025-2026 if trials are successful